» Articles » PMID: 33041853

The Dynamic Interplay Between Cardiac Inflammation and Fibrosis

Overview
Journal Front Physiol
Date 2020 Oct 12
PMID 33041853
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure is a leading cause of death worldwide. While there are multiple etiologies contributing to the development of heart failure, all cause result in impairments in cardiac function that is characterized by changes in cardiac remodeling and compliance. Fibrosis is associated with nearly all forms of heart failure and is an important contributor to disease pathogenesis. Inflammation also plays a critical role in the heart and there is a large degree of interconnectedness between the inflammatory and fibrotic response. This review discusses the cellular and molecular mechanisms contributing to inflammation and fibrosis and the interplay between the two.

Citing Articles

Free radicals and their impact on health and antioxidant defenses: a review.

Chandimali N, Bak S, Park E, Lim H, Won Y, Kim E Cell Death Discov. 2025; 11(1):19.

PMID: 39856066 PMC: 11760946. DOI: 10.1038/s41420-024-02278-8.


Taxifolin Protects Against 5-Fluorouracil-Induced Cardiotoxicity in Mice Through Mitigating Oxidative Stress, Inflammation, and Apoptosis: Possible Involvement of Sirt1/Nrf2/HO-1 Signaling.

Abukhalil M, Al-Alami Z, Alfwuaires M, Imran M, Aladaileh S, Althunibat O Cardiovasc Toxicol. 2025; 25(3):455-470.

PMID: 39827225 DOI: 10.1007/s12012-025-09962-w.


Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study.

Bo X, Li Q, Chen S, Zhou T, Yin N, Song W J Cardiothorac Surg. 2025; 20(1):66.

PMID: 39815292 PMC: 11736979. DOI: 10.1186/s13019-024-03238-0.


Cardiac effects and comorbidities of neurological diseases.

Ozturk B Turk J Med Sci. 2024; 54(7):1428-1437.

PMID: 39735485 PMC: 11673671. DOI: 10.55730/1300-0144.5928.


Non-invasive pressure-volume loop derived temporal elastance, contractility, and efficiency indices for assessing Duchenne muscular dystrophy patients.

Ajiboye I, Lang S, Taylor M, Banerjee R Heart Vessels. 2024; .

PMID: 39731610 DOI: 10.1007/s00380-024-02511-5.


References
1.
Sofat N, Robertson S, Wait R . Fibronectin III 13-14 domains induce joint damage via Toll-like receptor 4 activation and synergize with interleukin-1 and tumour necrosis factor. J Innate Immun. 2011; 4(1):69-79. PMC: 3250657. DOI: 10.1159/000329632. View

2.
Detillieux K, Sheikh F, Kardami E, Cattini P . Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res. 2002; 57(1):8-19. DOI: 10.1016/s0008-6363(02)00708-3. View

3.
Van Tassell B, Valle Raleigh J, Abbate A . Targeting interleukin-1 in heart failure and inflammatory heart disease. Curr Heart Fail Rep. 2014; 12(1):33-41. DOI: 10.1007/s11897-014-0231-7. View

4.
Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T . Predictors of outcome in patients with suspected myocarditis. Circulation. 2008; 118(6):639-48. DOI: 10.1161/CIRCULATIONAHA.108.769489. View

5.
Laroumanie F, Douin-Echinard V, Pozzo J, Lairez O, Tortosa F, Vinel C . CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation. 2014; 129(21):2111-24. DOI: 10.1161/CIRCULATIONAHA.113.007101. View